International Pharmaceutical Manufacturers Define Role in Responding to Non-Communicable Diseases

In preparation for the UN High Level Meeting on Non-Communicable Diseases, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) released its Framework for Action to outline the pharmaceutical industry’s focus in NCDs “The NCD framework is just the beginning; our vision is to work with others to identify what can be done in practice to help poor people access the care and treatment they need,” said IFPMA Director General Eduardo Pisani. “Together, we want to find ideas for concrete actions to put on the table in the aftermath of the UN NCD Summit in September. The Framework is our roadmap for this work.”  IFPMA’s Framework for Action centers on four main areas: innovation and research, access and affordability, prevention and health education, and partnerships.